ATC code L: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Drug navigation}} | |||
'''ATC code L''' is a section of the [[Anatomical Therapeutic Chemical Classification System]] (ATC), which is used for the classification of [[drugs]] and other [[medical]] substances. This code is part of a larger system used worldwide to facilitate the organization of [[medicine]] information, making it easier for healthcare professionals to prescribe and manage medications. | |||
== | == Overview == | ||
The ATC classification system divides active substances into different groups according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. ATC code L is specifically designated for [[Antineoplastic and Immunomodulating Agents]]. This group includes agents used primarily for the treatment of [[cancer]] (antineoplastics) and agents used to modify immune responses (immunomodulators). | |||
=== L02 Endocrine therapy | == Structure == | ||
* [[ | ATC code L is further divided into several subgroups: | ||
* [[ | * '''L01''' - [[Antineoplastic agents]] | ||
* '''L02''' - [[Endocrine therapy]] agents | |||
* '''L03''' - [[Immunostimulants]] | |||
* '''L04''' - [[Immunosuppressants]] | |||
Each of these subgroups is further divided into more specific classes based on the type of drug or its specific action mechanism. | |||
=== | === L01 - Antineoplastic Agents === | ||
This subgroup includes drugs used primarily for chemotherapy in cancer treatment. They are classified based on their chemical structure and mechanism of action, such as alkylating agents, antimetabolites, and plant alkaloids. | |||
== | === L02 - Endocrine Therapy === | ||
Drugs in this category are used to treat cancer by modulating the production or activity of hormones. This includes antiestrogens and aromatase inhibitors, which are commonly used in the treatment of breast cancer. | |||
== | === L03 - Immunostimulants === | ||
These are agents that stimulate the immune system to fight infection and disease. This subgroup includes interferons and interleukins, which are used in the treatment of various diseases, including some types of cancer. | |||
== | === L04 - Immunosuppressants === | ||
Immunosuppressants are drugs that suppress or reduce the strength of the body's immune system. They are primarily used in the prevention of organ transplant rejection and in the treatment of autoimmune diseases. | |||
== | == Usage == | ||
The ATC code L drugs are used in a variety of medical settings, including hospitals, outpatient clinics, and in home care, under the guidance of healthcare professionals specialized in oncology and immunology. | |||
== | == See also == | ||
* [[Chemotherapy]] | |||
* [[Immunotherapy]] | |||
* [[Oncology]] | |||
* [[Pharmacology]] | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category: | [[Category:ATC codes]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 17:25, 13 August 2024
ATC code L is a section of the Anatomical Therapeutic Chemical Classification System (ATC), which is used for the classification of drugs and other medical substances. This code is part of a larger system used worldwide to facilitate the organization of medicine information, making it easier for healthcare professionals to prescribe and manage medications.
Overview[edit]
The ATC classification system divides active substances into different groups according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. ATC code L is specifically designated for Antineoplastic and Immunomodulating Agents. This group includes agents used primarily for the treatment of cancer (antineoplastics) and agents used to modify immune responses (immunomodulators).
Structure[edit]
ATC code L is further divided into several subgroups:
- L01 - Antineoplastic agents
- L02 - Endocrine therapy agents
- L03 - Immunostimulants
- L04 - Immunosuppressants
Each of these subgroups is further divided into more specific classes based on the type of drug or its specific action mechanism.
L01 - Antineoplastic Agents[edit]
This subgroup includes drugs used primarily for chemotherapy in cancer treatment. They are classified based on their chemical structure and mechanism of action, such as alkylating agents, antimetabolites, and plant alkaloids.
L02 - Endocrine Therapy[edit]
Drugs in this category are used to treat cancer by modulating the production or activity of hormones. This includes antiestrogens and aromatase inhibitors, which are commonly used in the treatment of breast cancer.
L03 - Immunostimulants[edit]
These are agents that stimulate the immune system to fight infection and disease. This subgroup includes interferons and interleukins, which are used in the treatment of various diseases, including some types of cancer.
L04 - Immunosuppressants[edit]
Immunosuppressants are drugs that suppress or reduce the strength of the body's immune system. They are primarily used in the prevention of organ transplant rejection and in the treatment of autoimmune diseases.
Usage[edit]
The ATC code L drugs are used in a variety of medical settings, including hospitals, outpatient clinics, and in home care, under the guidance of healthcare professionals specialized in oncology and immunology.
See also[edit]
